STERIS plc provided earnings guidance for the fiscal 2023. For the year, constant currency organic revenue growth is anticipated to be approximately 11%. As reported revenue is expected to increase approximately 12%, reflecting the net impact of acquisitions and divestitures as well as the anticipated negative impact of foreign currency fluctuations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
223.4 USD | -2.52% | -3.13% | +1.61% |
05-20 | Steris Insider Sold Shares Worth $267,313, According to a Recent SEC Filing | MT |
05-17 | Steris Insider Sold Shares Worth $7,532,366, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.61% | 22.07B | |
-7.38% | 177B | |
-0.46% | 108B | |
-6.98% | 65.55B | |
+2.65% | 50.66B | |
+5.27% | 42.58B | |
+5.73% | 40.74B | |
+19.92% | 31.07B | |
+16.57% | 25.45B | |
-7.00% | 23.85B |
- Stock Market
- Equities
- STE Stock
- News STERIS plc
- STERIS plc Provides Earnings Guidance for Fiscal 2023